Pacira BioSciences (PCRX) Other Working Capital Changes (2010 - 2026)

Pacira BioSciences' Other Working Capital Changes history runs 17 years deep, the most recent figure standing at $4.5 million for Q1 2026.

• In Q1 2026, Other Working Capital Changes fell 12.77% year-over-year to $4.5 million; the TTM figure through Mar 2026 stood at $548000.0 (down 90.92% YoY), while the FY2025 annual figure was $1.2 million, up 2086.89% from the prior year.
• Other Working Capital Changes was $4.5 million for Q1 2026 at Pacira BioSciences, up from -$12.7 million in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $13.4 million in Q2 2025 to a low of -$12.7 million in Q4 2025.
• Historically, Other Working Capital Changes has averaged $791176.5 across 5 years, with a median of $2.1 million in 2022.
• The sharpest annual moves came in 2022 and 2024: Other Working Capital Changes surged 1777.17% in 2022, then slumped 232.76% in 2024.
• A 5-year view of Other Working Capital Changes shows it stood at $2.1 million in 2022, then sank by 190.24% to -$1.9 million in 2023, then plunged by 232.76% to -$6.4 million in 2024, then tumbled by 98.45% to -$12.7 million in 2025, then surged by 135.73% to $4.5 million in 2026.
• The last three Other Working Capital Changes figures came in at $4.5 million (Q1 2026), -$12.7 million (Q4 2025), and -$4.7 million (Q3 2025), per Business Quant data.